US CDC recommends Novavax’s COVID-19 vaccine for adults
The US government has secured 3.2 million Novavax vaccine doses, but is waiting for the company to finish quality testing before…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
EU signs COVID-19 drug procurement deal with Gilead
The new contract comes as Europe battles a burgeoning COVID wave spearheaded by the Omicron offshoot, BA.5
Australia provisionally approves Moderna’s COVID shot for children aged below five years
So far, the shot was provisionally approved in the country for individuals aged six years and older and as a booster dose for…
Bangladesh’s maiden homegrown COVID-19 vaccine gets clearance for human trials
The Bangavax vaccine, developed by local pharma company Globe Biotech, recently received clearance from the Directorate General of…
DCGI approves Themis Medicare’s Viralex as COVID-19 treatment
The drug is also effective for viruses causing viral respiratory infections
Health ministry seeks five crore free Covishield doses from GAVI under COVAX
Amid rising cases of coronavirus in the country, the government started providing precaution doses free of cost to those aged 18…
Glenmark Pharma and SaNOtize announce results of its phase-III clinical trials on SaNOtize’s Nitric…
The trial administered to adult COVID-19 patients in India met the key endpoints and demonstrated reductions of viral load of 94…
US secures 3.2 million doses of COVID-19 vaccine by Novavax
The US Department of Health and Human Services (HHS), in collaboration with the Department of Defence (DOD), announced that it has…
Moderna to advance two Omicron vaccine candidates against newer variants
Moderna said its decision to develop the bivalent vaccines was based on different market preferences for shots against the…
Antibody therapy less effective against new Omicron strains: Lancet
A team of researchers, including those from the German Primate Center (DPZ)-Leibniz Institute for Primate Research in Germany,…
Novavax expects COVID vaccine targetting Omicron in fourth quarter
The company's vaccine, based on an earlier strain of the virus, has not yet been authorised in the US, and is currently under FDA…
Serum Institute seeks nod to export 32.4 lakh doses of its COVID vaccine Covovax to US
It will be the first vaccine to be exported to the country by any Indian manufacturer, according to official sources
DCGI approves India’s maiden mRNA vaccine against COVID-19
The vaccine by Geneva Biopharma will be sold under the brand name Gemcovac-19
China’s Clover says its COVID booster shot candidate lifts antibody against Omicron
The booster shot also elicited a 12-fold rise in the neutralising antibody level against the BA.1 subvariant, the company said,…
Government panel recommends emergency approval for SII’s Covovax for seven-11 year olds
The recommendation has been sent to the Drugs Controller General of India (DCGI) for final approval
Sanofi, GSK COVID-19 vaccine found effective against Omicron
The vaccine targets the beta variant – first identified in South Africa – as well as the original Wuhan strain of the virus
DCGI panel to review today SII applications for Covovax’s use among kids aged 2-7 years, 7-11…
The expert panel in its last meeting in April had sought more data from SII following its application seeking the Emergency Use…
Biological E gets WHO nod to be additional facility for making Johnson & Johnson COVID vaccine
The DCGI recently approved Corbevax as a precaution dose for those aged 18 and above
Ocugen announces positive results for COVID-19 vaccine trial for children aged two-18 years
Ocugen’s partner Bharat Biotech’s phase-II/III study of Covaxin (BBV152) in 526 children showed safety, efficacy, and superior…
TRIPS waiver deal in WTO to help countries make COVID-19 vaccines: Piyush Goyal
Goyal said that India already has a number of COVID vaccines and can help other developing countries to make vaccines